Vicarious Surgical (RBOTW) Total Debt (2021 - 2022)

Vicarious Surgical (RBOTW) reported Total Debt of $850000.0 for Q3 2022, down 40.81% year-over-year from $1.4 million in Q3 2021, and down 14.31% quarter-over-quarter from $992000.0 in Q2 2022.

Vicarious Surgical (RBOTW) Total Debt (2021 - 2022) Analysis & Trends

Vicarious Surgical (RBOTW) has 2 years of Total Debt data on file, last reported at $850000.0 in Q3 2022.

  • Total Debt for Q3 2022 came in at $850000.0, down 40.81% year-over-year; the trailing twelve-month figure through Sep 2022 was $850000.0 (down 40.81% YoY), and the FY2021 annual result was $1.3 million, changed N/A from the prior year.
  • Total Debt slipped to $850000.0 in Q3 2022 per RBOTW's latest filing, from $992000.0 in the prior quarter.
  • Over five years, Total Debt peaked at $1.4 million in Q3 2021 and troughed at $850000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 34.05 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 14.72 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 28.07 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.48 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.93 Bn
10 Vicarious Surgical - - - -

Historic Data

Download Data
DateValue
Sep 30, 2022 850,000.00
Jun 30, 2022 992,000.00
Mar 31, 2022 1.13 Mn
Dec 31, 2021 1.28 Mn
Sep 30, 2021 1.44 Mn